We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » US FDA Provides ‘Closeout Letters’ to Warning Letter Recipients
US FDA Provides ‘Closeout Letters’ to Warning Letter Recipients
September 17, 2009
Drugmakers that have resolved issues in warning letters from the U.S. Food and Drug Administration (FDA) dated Sept. 1 or later — and have passed inspections that verify the corrective action — are eligible for closeout letters.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor